System and method for digital, multiplexed, extracellular vesicle-derived biomarker diagnostic lab-on-a-chip and method of use thereof

The digital, multiplexed lab-on-a-chip system employs DEP for sensitive biomarker detection from biological samples, addressing the limitations of current methods by offering a minimally invasive and cost-effective solution for early disease detection through the isolation and analysis of EV biomarkers.

WO2024238971A1PCT designated stage expired Publication Date: 2024-11-21RICE BRYAN JOSEPH
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
PCT/US2024/030054
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-05-17
Filing Date
2024-05-17
Publication Date
2024-11-21

AI Technical Summary

Technical Problem

Current methods for detecting disease biomarkers, such as cancer, are invasive, costly, and lack sensitivity and specificity, particularly for early disease detection, while existing EV biomarker tests rely on fluorescence-based detection which is limited in sensitivity and specificity.

Method used

A digital, multiplexed lab-on-a-chip system using a filter cartridge with dielectrophoresis (DEP) for label-free, non-mechanical isolation of extracellular vesicle-derived biomarkers from biological samples, enabling sensitive and specific detection through a software-controlled device for processing and analysis.

Benefits of technology

The system provides a minimally invasive, cost-effective, and highly sensitive method for early disease detection, capable of isolating and analyzing EV biomarkers from biological fluids, improving upon existing methods by enhancing sensitivity and specificity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure US2024030054_21112024_PF_FP_ABST
    Figure US2024030054_21112024_PF_FP_ABST
Patent Text Reader

Abstract

The present invention is directed to a system and method, for digital, multiplexed, extracellular vesicle-derived biomarker diagnostic lab-on-a-chip and method of use thereof. The present invention provides a minimally invasive system and method for early disease detection using extracellular vesicles as biomarkers for disease. Extracellular vesicles are collected from a fluid biological sample and subjected to a sorting process which provide a purified liquid containing the biomarkers of interest.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Ex-Vivo Multi-Dimensional System For The Separation And Isolation Of Cells, Vesicles, Nanoparticles, And Biomarkers

    US20140048417A1

  • Sensor monitoring system for in-dwelling catheter based treatments

    US20190358387A1

  • Determining extracellular analyte concentration with nanoplasmonic sensors

    US20200158639A1

  • Method and Apparatus for Isolating and Detecting Biological and Other Particles

    US20210331166A1

  • Method, automated system and cartridge for extraction of cell-free nucleic acids from a blood sample

    US20230028621A1